• Dormakaba reaffirmed its fiscal 2026/27 outlook for organic sales growth above 3%.
• Guidance also targets an operating EBIT margin above 11% and an operating cash flow margin of 10.5%-11.5%.
• First-quarter net sales rose 5.2% to CHF 702.9 million, with organic growth of 4%.
• Organic growth reflected price increases of 2.7% and volume growth of 1.3%.
• Access Solutions maintained a strong order backlog.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DORMAKABA Holding AG published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2423386_de) on October 28, 2026, and is solely responsible for the information contained therein.